CVS Health Corporation
CVS Health Corporation Issues Junior Subordinated Notes
Summary
On December 10, 2024, CVS Health Corporation issued $2.25 billion aggregate principal amount of 7.000% Fixed-to-Fixed Rate Series A Junior Subordinated Notes due 2055 and $750 million aggregate principal amount of 6.750% Fixed-to-Fixed Rate Series B Junior Subordinated Notes due 2054. The issuance was made under the Company's Registration Statement on Form S-3ASR and the notes are governed by a Subordinated Indenture. Relevant exhibits include the Base Indenture, Supplemental Indentures, and forms of the notes.
Profitelligence Alerts
Get alerts for CVS
Be first to know when CVS Health Corporation files with the SEC.
Filing Categories
Exhibits (4)
Advertisement
About CVS Health Corporation
CVS Health Corporation is a leading health services company in the United States, offering a comprehensive range of services aimed at improving healthcare accessibility and convenience. Primarily known for its extensive network of pharmacies, CVS Health operates thousands of retail locations nationwide. These outlets provide prescription medications, over-the-counter drugs, health and wellness products, and immunization services. Beyond retail, CVS Health plays a significant role in the healthcare sector through its pharmacy benefit management division, Caremark, which administers prescription drug plans for insurers and employers. Additionally, the company owns Aetna, a major health insurance provider, aligning its services across retail, pharmacy benefits, and insurance solutions to deliver integrated healthcare experiences. With its broad reach and diverse healthcare offerings, CVS Health Corporation holds a critical place in the healthcare market, continuously working to streamline and enhance the delivery of medical services across the country.
Official SEC Documents
Advertisement